ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: BCR-ABL; SB mice were found to have decreased survival, indicators of disease progression (increased terminal WBCs, decreased hemoglobin, increased spleen and liver weights), and changes in expression of genes previously implicated in CML progression when compared to BCR-ABL-only mice (104).